A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of cardiovascular disease.

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

Neurons in the brains of mice tell them to stop eating when they’ve had enough food – and since people probably have the same ...

In line with trial results, real-world data suggest GLP-1 receptor agonists have certain benefits in patients with moderate to severe chronic kidney disease (CKD).

A high-resolution spatial map of the human hypothalamus makes it possible to identify specific cells, determine their exact ...

While older anti-obesity drugs may lead to less weight loss than semaglutide and tirzepatide, they remain useful tools in ...

People with type 2 diabetes typically have impaired GLP-1 function, leading to difficulties in blood sugar control. Medications like Ozempic and other GLP-1 agonists mimic the action of this ...

Fractyl Health is deprioritizing a type 2 diabetes trial in favor of a pivotal study of its endoscopy treatment Revita and parting with around 22 employees in an attempt to extend its runway into 2026 ...